Archive: 30/03/2015

Teva buying Auspex for $3.2 billion

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

page 8 from 11